Pierre Rémy

Gründer bei

Keensight Capital SAS

59 Jahre

24 Beziehungen

Health Technology

Consumer Services

Finance

Profil

Pierre Rémy is the founder of Keensight Capital SAS, which was founded in 2013.
He is currently the Chairman of Biovian Oy and a Director at LDR Spine USA, Inc. He previously held positions as a Director at LDR Holding Corp.
and a Member-Supervisory Board at Crossject SA. He will serve as a Member-Supervisory Board at Unifin SAS from 2019 to 2023.
Mr. Rémy holds an MBA from Sciences Po and a graduate degree from Arts Et Metiers Paristech.

Aktive Positionen von Pierre Rémy

Unternehmen	Position	Beginn
Keensight Capital SAS Keensight Capital SAS Investment ManagersFinance Keensight is an active manager which focuses on investments in innovative technologies. They invest in companies based on Information and Communications Technologies, particularly as applied to network throughput improvement, networks interconnectivity and convergence, network safety, data storage management and logistics. They have invested in software companies, semi conductors and telecommunications, as well as in medical technology. Their geographic focus is on Europe and particularly France. The firm favors mature businesses and generally participates in second and subsequent financing rounds. They target companies with proven technology, an already established clientele, a leading market position and high-growth potential. They promote the international expansion of their investee companies.	Gründer	01.11.2013
LDR Spine USA, Inc. LDR Spine USA, Inc. Medical SpecialtiesHealth Technology Offers sterile spinal implant systems	Direktor/Vorstandsmitglied	-
Biovian Oy Biovian Oy Pharmaceuticals: MajorHealth Technology Provides contract manufacturing and development of biopharmaceuticals	Vorsitzender	-

Alle aktiven Positionen von Pierre Rémy

Ehemalige bekannte Positionen von Pierre Rémy

Unternehmen	Position	Ende
Unifin SAS Unifin SAS Medical SpecialtiesHealth Technology Engages in the production and packaging sterile liquids	Direktor/Vorstandsmitglied	16.04.2023
LDR HOLDING CORP	Direktor/Vorstandsmitglied	-
CROSSJECT	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Pierre Rémy im Detail an

Ausbildung von Pierre Rémy

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Pierre Rémy im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	8
LDR Spine USA, Inc. LDR Spine USA, Inc. Medical SpecialtiesHealth Technology Offers sterile spinal implant systems	Health Technology
LDR Holding Corp. LDR Holding Corp. Medical SpecialtiesHealth Technology Engages in designing and commercializing of novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders	Health Technology
Crossject SA Crossject SA Medical SpecialtiesHealth Technology Designs and develops needle free, pre-filled single-use injection systems	Health Technology
Sciences Po Sciences Po Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Arts Et Metiers Paristech Arts Et Metiers Paristech Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Keensight Capital SAS Keensight Capital SAS Investment ManagersFinance Keensight is an active manager which focuses on investments in innovative technologies. They invest in companies based on Information and Communications Technologies, particularly as applied to network throughput improvement, networks interconnectivity and convergence, network safety, data storage management and logistics. They have invested in software companies, semi conductors and telecommunications, as well as in medical technology. Their geographic focus is on Europe and particularly France. The firm favors mature businesses and generally participates in second and subsequent financing rounds. They target companies with proven technology, an already established clientele, a leading market position and high-growth potential. They promote the international expansion of their investee companies.	Finance
Biovian Oy Biovian Oy Pharmaceuticals: MajorHealth Technology Provides contract manufacturing and development of biopharmaceuticals	Health Technology
Unifin SAS Unifin SAS Medical SpecialtiesHealth Technology Engages in the production and packaging sterile liquids	Health Technology